Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
7.86
-0.04 (-0.51%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Journey Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 25.64 | 24.09 | 20.31 | 27.44 | 32 | 49.08 |
Cash & Short-Term Investments | 25.64 | 24.09 | 20.31 | 27.44 | 32 | 49.08 |
Cash Growth | 26.36% | 18.64% | -26.00% | -14.26% | -34.80% | 495.21% |
Receivables | 36.25 | 29.78 | 10.23 | 15.22 | 28.21 | 23.11 |
Inventory | 8.16 | 9.62 | 14.43 | 10.21 | 14.16 | 9.86 |
Prepaid Expenses | 2.74 | 3.38 | 3.21 | 3.59 | 3.31 | 2.44 |
Total Current Assets | 72.78 | 66.87 | 48.18 | 56.46 | 77.68 | 84.49 |
Property, Plant & Equipment | 0.07 | 0.11 | 0.2 | 0.1 | 0.19 | 0.09 |
Other Intangible Assets | 25.51 | 27.61 | 31.86 | 20.29 | 27.2 | 12.55 |
Other Long-Term Assets | - | - | - | 0.01 | 0.1 | 0.15 |
Total Assets | 98.36 | 94.59 | 80.24 | 76.85 | 105.16 | 97.28 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.05 | 8.85 | 16.05 | 18.15 | 36.57 | 22.81 |
Accrued Expenses | 29.72 | 26.24 | 15.23 | 16.49 | 16.27 | 20.09 |
Short-Term Debt | - | - | - | - | 2.95 | 0.81 |
Current Portion of Long-Term Debt | 5 | - | 0.63 | 3 | 2.24 | 4.51 |
Current Portion of Leases | 0.07 | 0.1 | 0.08 | 0.1 | 0.08 | 0.1 |
Current Income Taxes Payable | - | 0.07 | 0.06 | 0.05 | 0.04 | 0.01 |
Other Current Liabilities | 2.93 | 2.18 | 3.12 | 4.08 | 8.68 | 3.28 |
Total Current Liabilities | 45.77 | 37.44 | 35.18 | 41.87 | 66.83 | 51.61 |
Long-Term Debt | 20.47 | 25.28 | 24.88 | 14.62 | 21.24 | 3.63 |
Long-Term Leases | - | 0.02 | 0.12 | 0.01 | 0.11 | - |
Total Liabilities | 66.24 | 62.74 | 60.17 | 56.5 | 88.18 | 55.24 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 133.11 | 130.31 | 107.09 | 92.7 | 85.48 | 80.92 |
Retained Earnings | -101 | -98.46 | -87.03 | -72.36 | -68.5 | -38.87 |
Shareholders' Equity | 32.11 | 31.85 | 20.07 | 20.35 | 16.98 | 42.04 |
Total Liabilities & Equity | 98.36 | 94.59 | 80.24 | 76.85 | 105.16 | 97.28 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 25.54 | 25.4 | 25.71 | 17.73 | 26.62 | 9.05 |
Net Cash (Debt) | 0.1 | -1.31 | -5.4 | 9.71 | 5.38 | 40.03 |
Net Cash Growth | - | - | - | 80.40% | -86.56% | - |
Net Cash Per Share | 0.00 | -0.05 | -0.26 | 0.53 | 0.31 | 3.93 |
Filing Date Shares Outstanding | 28.22 | 27.33 | 23.1 | 19.93 | 17.83 | 17.32 |
Total Common Shares Outstanding | 27.66 | 27.14 | 22.15 | 19.32 | 17.77 | 17.32 |
Working Capital | 27.01 | 29.43 | 13 | 14.59 | 10.85 | 32.88 |
Book Value Per Share | 1.16 | 1.17 | 0.91 | 1.05 | 0.96 | 2.43 |
Tangible Book Value | 6.6 | 4.25 | -11.79 | 0.06 | -10.22 | 29.49 |
Tangible Book Value Per Share | 0.24 | 0.16 | -0.53 | 0.00 | -0.57 | 1.70 |